Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Market Cap

Arrowhead Pharmaceuticals has a market cap or net worth of $7.94 billion as of March 23, 2026. Its market cap has increased by 256.15% in one year.

• Market Cap: 7.94B
• Enterprise Value: 7.72B
• 1-Year Change: 256.15%
• Ranking: #1013
• Category: Mid-Cap
• Stock Price: $56.67

Market Cap Chart

Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $7.94B, an increase of 2,645,108.07%. That is a compound annual growth rate of 58.23%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	7.89B	-12.51%
Dec 31, 2025	9.02B	285.42%
Dec 31, 2024	2.34B	-28.84%
Dec 29, 2023	3.29B	-23.54%
Dec 30, 2022	4.30B	-37.84%
Dec 31, 2021	6.92B	-11.95%
Dec 31, 2020	7.86B	29.67%
Dec 31, 2019	6.06B	451.13%
Dec 31, 2018	1.10B	299.42%
Dec 29, 2017	275.20M	154.58%
Dec 30, 2016	108.10M	-70.48%
Dec 31, 2015	366.20M	-9.27%
Dec 31, 2014	403.60M	-3.88%
Dec 31, 2013	419.90M	1,153.43%
Dec 31, 2012	33.50M	-24.04%
Dec 30, 2011	44.10M	-31.42%
Dec 31, 2010	64.30M	93.09%
Dec 31, 2009	33.30M	-15.70%
Dec 31, 2008	39.50M	-72.93%
Dec 31, 2007	145.90M	-2.60%
Dec 29, 2006	149.80M	25.99%
Dec 30, 2005	118.90M	101.87%
Dec 31, 2004	58.90M	19,533.33%
Jan 15, 2004	300.00K	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
ABIVAX Société Anonyme	9.37B
ImmunityBio	8.71B
Praxis Precision Medicines	8.31B
Bio-Techne	8.05B
Axsome Therapeutics	8.03B
Vaxcyte	7.88B
Cytokinetics	7.60B
Halozyme Therapeutics	7.49B